Option chain shows key data for Actuate Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Actuate Therapeutics.

Actuate Therapeutics (NASDAQ:ACTU) Stock, Option Chain

Actuate Therapeutics

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

Stock Movers

ACTU

ALVO

BACK

CSBR

EVGR

GLRE

HEPA

JDZG

JYNT

LUNG

PRTA

SRRK

UNTY

VREX

YIBO

ZKIN

Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket

Intel, Cleanspark, Super Micro Computer, Upstart, Tesla: Why These 5 Stocks Are On Investors' Radars Today

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AVGO

BURU

CADL

CHCI

EVGO

GXAI

LAES

LICN

LOOP

NFBK

PLRX

PRLH

RPTX

TRUG

Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Earnings

Actuate Reports Third Quarter 2010 Financial Results: EPS of $0.23

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics Inc

Piper Sandler analyst Arvind Ramnani reiterates Upstart Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) with a Overweight and raises the price target from $85 to $105.

Price Target

Reiteration

Analyst Ratings

UPST

Piper Sandler Reiterates Overweight on Upstart Hldgs, Raises Price Target to $105

Piper Sandler analyst Clarke Jeffries maintains Shopify (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) with a Neutral and raises the price target from $94 to $104.

SHOP

Piper Sandler Maintains Neutral on Shopify, Raises Price Target to $104

Piper Sandler analyst Brent Bracelin maintains Freshworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>) with a Overweight and raises the price target from $20 to $24.

FRSH

Piper Sandler Maintains Overweight on Freshworks, Raises Price Target to $24

On Tuesday, Alphabet Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google confirmed that its annual developer conference, Google I/O 2025, will take place on May 20-21 at the Shoreline Amphitheater in Mountain View, California.
What Happened: As one of the most anticipated tech events of the year, Google I/O brings together developers, engineers, and tech enthusiasts.
The company will use the event to showcase major advancements in artificial intelligence, Android, and cloud computing.
See Also:&nbsp;<a href="https://www.benzinga.com/25/02/43646615/top-analyst-says-metas-ai-push-could-add-100-per-share-while-tesla-faces-ev-headwindswhy-hes-still-bullish-on-musks-robotics-vision" target="_blank" rel="noreferrer noopener">Meta's AI Push Could Add $100 Per Share While Tesla Faces EV Headwinds: Top Analyst</a>
The first day, May 20, will begin with the highly anticipated Google Keynote, followed by the Developer Keynote. The rest of the day will feature product demos, Q&amp;A sessions, and networking events, including a developer block party.
The second day, May 21, will continue with in-depth technical sessions and more opportunities for attendees to engage with Google engineers.
Registration for the free event is now open, and for those unable to attend in person, the keynotes will be streamed live on YouTube.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
What To Expect: Google I/O has traditionally been the stage for unveiling major software updates, including new versions of Android and advancements in Google's AI initiatives. Last year, <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38825276/google-io-2024-to-spotlight-ai-innovations-and-new-monetization-opportunities-analy">the company introduced</a> Gemini Live and showcased multiple AI-driven features.
This year, AI is expected to take center stage once again. Google could announce new updates for Gemini AI, unveil Android 16, and improvements to Google Search, Assistant, and Workspace.
There is also speculation about whether Google will unveil the Pixel 9a at the event. In past years, Google introduced its Pixel &#8220;a&#8221; series at I/O, but last year, it broke tradition by revealing the Pixel 8a through a marketing campaign instead.
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://in.benzinga.com/media/25/02/43646042/elon-musks-97-4-billion-openai-takeover-bid-reportedly-not-received-by-chatgpt-parent-another-one-of-his-tactics-says-sam-altman" target="_blank" rel="noreferrer noopener">Elon Musk&#8217;s $97.4 Billion OpenAI Takeover Bid Reportedly Not Received By ChatGPT Parent: ‘Another One Of His Tactics,&#8217; Says Sam Altman</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image Via Shutterstock

Tech

GOOG

GOOGL

Google I/O 2025 Officially Set For May — Here's What To Expect, From AI Breakthroughs To The Future Of Android And Pixel 9a

Morgan Stanley analyst Michael Ulz downgrades Third Harmonic Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRD#NASDAQ">THRD</a>) from Overweight to Equal-Weight and lowers the price target from $20 to $5.

Downgrades

THRD

Morgan Stanley Downgrades Third Harmonic Bio to Equal-Weight, Lowers Price Target to $5

Meta Platforms Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) is reportedly in negotiations to acquire&nbsp;FuriosaAI Inc., a Seoul-based AI chip startup. The acquisition deal is expected to&nbsp;be finalized as early as&nbsp;this month.
What Happened: Mark Zuckerberg&#8216;s Meta is in discussions to acquire FuriosaAI, a South Korean AI chip startup founded by June Paik, a former Samsung (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>)and Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) engineer, according to a Forbes <a href="https://www.forbes.com/sites/johnkang/2025/02/11/meta-in-talks-to-buy-korean-ai-chip-startup-founded-by-samsung-engineer/">report</a> on Tuesday. FuriosaAI specializes in developing accelerators that optimize AI applications and has created its own AI chip, Warboy in 2021, after which it launched the advanced accelerator chip RNGD in August.
"RNGD will be an ideal choice for the large-scale deployment of advanced generative AI models such as Meta&#8217;s Llama 2 and Llama 3," stated FuriosaAI.
CEO Paik has previously highlighted the need for an alternative semiconductor ecosystem, citing the high cost and limited supply of Nvidia&#8217;s AI accelerators. FuriosaAI&#8217;s models reportedly offer a more cost-effective solution, with system chip construction costs amounting to about half of Nvidia&#8217;s.
SEE ALSO: <a href="https://www.benzinga.com/markets/equities/25/02/43591228/sam-altmans-openai-set-to-finalize-in-house-ai-chip-reducing-dependence-on-nvidia-report">Sam Altman&#8217;s OpenAI Set To Finalize In-House AI Chip, Reducing Dependence On Nvidia: Report</a>
Why It Matters: This move by the Zuckerberg-led company comes in the wake of aggressive AI initiatives that have been driving the company&#8217;s growth. According to Wedbush analyst Dan Ives, <a href="https://www.benzinga.com/25/02/43646615/top-analyst-says-metas-ai-push-could-add-100-per-share-while-tesla-faces-ev-headwindswhy-hes-still-bullish-on-musks-robotics-vision">Meta&#8217;s AI-driven monetization</a> strategy could potentially add an incremental $100 per share.
The acquisition talks are also happening at a time when Meta Platforms is looking to challenge&nbsp;Nvidia Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)&nbsp;and lessen its strong dependence on the world&#8217;s leading GPU manufacturer for AI chips. Last month, Meta revealed that its capital expenditures could reach up to $65 billion in 2025, with a substantial share dedicated to AI infrastructure investments.
Conrad van Tienhoven, a portfolio manager at Riverpark Capital told Bloomberg, "I have long viewed Meta as the biggest beneficiary of AI outside of maybe Nvidia, and I think more people are coming around to that idea.&#8221; Tienhoven elucidated that Meta's investment has reshaped its approach to ad targeting and measurement, leading to enhanced growth and increased average revenue per user.
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/insights/news/25/02/43644404/100-invested-in-nvidia-20-years-ago-would-be-worth-this-much-today">$100 Invested In NVIDIA 20 Years Ago Would Be Worth This Much Today</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

NVDA

SSNLF

Mark Zuckerberg's Meta Eyes Acquisition Of Korean AI Chip Startup Founded By Former Samsung And AMD Engineer

Former Treasury Secretary Larry Summers warned of heightened inflation risks, citing tight labor markets and potential policy shifts, as markets dramatically scaled back expectations for Federal Reserve rate cuts in 2025.
What Happened: &#8220;This is probably the most sensitive moment we&#8217;ve had for an escalation in inflation since the policy errors of 2021,&#8221; Summers <a href="https://www.bloomberg.com/news/articles/2025-02-11/summers-sees-biggest-inflation-breakout-risk-since-2021-errors">said</a> on Bloomberg Television&#8217;s Wall Street Week, pointing to January&#8217;s strong wage growth data and tightening labor market conditions.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This is probably the most sensitive moment we've had for an escalation in inflation since the policy errors of 2021 that set off the significant inflation that we had.<a href="https://t.co/A1Y5cUvhbN">https://t.co/A1Y5cUvhbN</a>
&mdash; Lawrence H. Summers (@LHSummers) <a href="https://twitter.com/LHSummers/status/1889435210644599002?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Economist Peter Schiff echoed inflation concerns, arguing on social media platform X that the Federal Reserve&#8217;s previous 40% increase in money supply inherently creates inflation. &#8220;It&#8217;s not that money supply growth could cause inflation, but that, by definition, it is inflation. It&#8217;s because the Fed creates inflation that prices go up.&#8221; Schiff wrote. 
Meanwhile, Fed Chair Jerome Powell maintained a <a href="https://in.benzinga.com/economics/macro-economic-events/25/02/43628752/feds-powell-reiterates-no-hurry-to-cut-interest-rates-as-inflation-remains-somewhat-elevated">cautious stance during Tuesday&#8217;s Senate testimony</a>, emphasizing that policymakers are in no &#8220;hurry&#8221; to adjust rates while inflation remains &#8220;somewhat elevated.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Fed Chair Powell said a 40% increase in the money supply in a short period of time could possibly cause some inflation. It&#39;s not that money supply growth could cause inflation, but that, by definition, it is inflation. It&#39;s because the Fed creates inflation that prices go up.
&mdash; Peter Schiff (@PeterSchiff) <a href="https://twitter.com/PeterSchiff/status/1889390023515975824?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The S&amp;P 500, tracked by SPDR S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), has risen 4.11% over the past month, trading at $605.31 as of Tuesday. The Nasdaq-100, tracked by Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), is up 4.44% in the same period, trading at $527.99. Meanwhile, Dow Jones Industrial Average Futures are at 44,678.00 USD, down 30.00 points or 0.06% today, according to <a href="https://www.benzinga.com/pro/">data from Benzinga Pro</a>.
See Also: <a href="https://www.benzinga.com/markets/equities/25/02/43646506/dan-ives-says-palantir-could-be-next-oracle-or-salesforce-as-ai-boom-drives-massive-software-spending-highlights-8-10x-multiplier-effect">Dan Ives Says Palantir Could Be Next Oracle Or Salesforce As AI Boom Drives Massive Software Spending, Highlights 8-10x Multiplier Effect</a>
Why It Matters: Recent economic indicators have <a href="https://www.benzinga.com/economics/macro-economic-events/25/02/43608052/traders-rethink-interest-rate-path-as-inflation-concerns-resume-feds-rate-cutting-cycle-is-over-economist-says">fueled these concerns</a>. The University of Michigan&#8217;s consumer sentiment survey showed one-year inflation expectations jumping to 4.3%, while the U.S. five-year breakeven rate climbed to 2.59%, up from 1.89% in September.
Bank of America economist Aditya Bhave suggested that &#8220;the Fed&#8217;s rate-cutting cycle is over,&#8221; as January&#8217;s employment data showed the labor market stabilizing around full employment. The unemployment rate unexpectedly dropped to 4.1%, with wage growth accelerating despite <a href="https://www.benzinga.com/economics/macro-economic-events/25/02/43608052/traders-rethink-interest-rate-path-as-inflation-concerns-resume-feds-rate-cutting-cycle-is-over-economist-says">weather-impacted headline numbers</a>.
Goldman Sachs economists noted that markets might be underpricing inflation risks, particularly given the potential impacts from proposed tariff increases and uncertainty in <a href="https://www.benzinga.com/economics/macro-economic-events/25/02/43608052/traders-rethink-interest-rate-path-as-inflation-concerns-resume-feds-rate-cutting-cycle-is-over-economist-says">trade policy outcomes</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43646173/bitcoin-ethereum-dogecoin-dip-even-as-fed-chair-powell-says-no-to-cbdcs-analyst-says-btc-under-consolidation-but-next-big-move-could-be-likely">Bitcoin, Ethereum, Dogecoin Dip Even As Fed Chair Powell Says No To CBDC: Analyst Says BTC Under Consolidation But &#8216;Next Big Move&#8217; Likely</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Economics

Federal Reserve

Larry Summers And Peter Schiff Warn Of Rising Inflation Risks As Markets Slash Fed Rate Cut Expectations: 'Most Sensitive Moment'

Shares of Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) have skyrocketed by 17.47% over the last 17 days, reregistering one of the longest winning streaks for the company led by Mark Zuckerberg, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025719/Meta-Over-Last-18-Days-1024x576.png" alt="" class="wp-image-777978" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025719/Meta-Over-Last-18-Days-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025719/Meta-Over-Last-18-Days-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025719/Meta-Over-Last-18-Days-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025719/Meta-Over-Last-18-Days-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025719/Meta-Over-Last-18-Days.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
What Happened: The stock trades at $719.80 apiece as of Tuesday&#8217;s close, which is about 0.7% shy of its 52-week high of $725.01 per share.
Despite the constant surge in the stock, Meta&#8217;s over-optimistic momentum indicators hint at a likely pullback.
The company&#8217;s simple daily moving averages hinted at a bullish uptrend, owing to strength in the stock, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. The share price was much above its 200-day simple moving average of $548.26, and 50-day average of $630.51. It is also higher than its eight-day average of $707.43 and the 20-day average of $665.82.
The momentum indicators were also very strong. The relative strength index of 80.70, coupled with a positive MACD (moving average convergence/divergence) indicator of 28.44 showed that the stock was overbought. These strong upward trends suggest that the stock could be nearing exhaustion, signaling a potential short-term pullback or consolidation phase.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025743/Meta-tech-Chart-1024x576.png" alt="" class="wp-image-777987" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025743/Meta-tech-Chart-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025743/Meta-tech-Chart-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025743/Meta-tech-Chart-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025743/Meta-tech-Chart-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025743/Meta-tech-Chart.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
See Also: <a href="https://www.benzinga.com/general/market-summary/25/02/43491799/meta-ai-models-clearly-behind-deepseek-says-analysts-after-mark-zuckerberg-admitted-deepseek-did-some-novel-things-were-still-digesting">Meta AI Models &#8216;Clearly Behind&#8217; DeepSeek, Says Analyst After Mark Zuckerberg Admits DeepSeek Did Some Novel Things &#8216;We&#8217;re Still Digesting&#8217;</a>
Why It Matters: Despite the recent stock surge, Meta faces <a href="https://www.benzinga.com/general/market-summary/25/02/43491799/meta-ai-models-clearly-behind-deepseek-says-analysts-after-mark-zuckerberg-admitted-deepseek-did-some-novel-things-were-still-digesting">headwinds</a> in the AI race, according to Piper Sandler. Their research note dated Feb. 4, positioned DeepSeek&#8217;s AI model ahead of Meta's latest Llama model.
However, Wedbush analyst Dan Ives <a href="https://www.benzinga.com/25/02/43646615/top-analyst-says-metas-ai-push-could-add-100-per-share-while-tesla-faces-ev-headwindswhy-hes-still-bullish-on-musks-robotics-vision">remains bullish</a>, he recently highlighted Meta&#8217;s AI monetization strategy on CNBC.
&#8220;It&#8217;s about monetizing those three and a half billion DAUs,&#8221; he said, adding that AI innovations &#8220;could be an incremental $100 per share&#8221; for Meta as the company ramps up its efforts.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We believe Meta is in a very strong position to further monetize AI over the coming years as Zuck drives the vision and puts massive cap-ex behind this AI initiative in 2025 <a href="https://twitter.com/CNBCWEX?ref_src=twsrc%5Etfw">@CNBCWEX</a> <a href="https://twitter.com/FrankCNBC?ref_src=twsrc%5Etfw">@FrankCNBC</a> &#x1f525;&#x1f3c6;&#x1f402;&#x1f37f;&#x1f4fa;&#x1f447; <a href="https://twitter.com/CNBC?ref_src=twsrc%5Etfw">@CNBC</a> <a href="https://t.co/DmU2qc3ag8">https://t.co/DmU2qc3ag8</a>
&mdash; Dan Ives (@DivesTech) <a href="https://twitter.com/DivesTech/status/1889294401362387207?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Price Action: Meta rose by 0.33% on Tuesday and advanced further by 0.01% in after-hours, whereas the exchange-traded fun tracking Nasdaq 100 index, Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell 0.24%.
Meta shares have gained 20.12% on a year-to-date basis, whereas it was up by 53.51% over the last year.
The average price target among 43 <a href="https://www.benzinga.com/quote/META/analyst-ratings">analysts tracked by Benzinga</a> is $731.76 with a ‘buy' rating. The estimates range from $575 to $935 apiece. Recent ratings from Tigress Financial, UBS, and Citigroup suggest a $833.67 target, implying a potential upside of 15.81%.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/META/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="381" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025539/Meta-ANR-FIn-1024x381.png" alt="" class="wp-image-777974" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025539/Meta-ANR-FIn-1024x381.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025539/Meta-ANR-FIn-300x112.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025539/Meta-ANR-FIn-768x285.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025539/Meta-ANR-FIn.png 1060w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43647586/coca-cola-won-overall-share-from-pepsi-maaza-crosses-1-billion-milestone-analyst-says-never-seen-fundamentals-this-good-amid-strong-2025-outlook">Coca-Cola &#8216;Won Overall Share&#8217; From Pepsi: Analyst Says &#8216;Never Seen Fundamentals This Good,&#8217; Amid Strong 2025 Outlook </a></li>
</ul>
Image via Shutterstock

Analyst Color

Market Summary

Broad U.S. Equity ETFs

Technicals

ETFs

General

Meta Stock Surges 17.47% In 17 Days, Marking One Of Its Longest Winning Streaks—Analysts Say There's Still Room For Double-Digit Growth For Mark Zuckerberg's Company

ACRE

AEIS

AEMD

ALCO

ALKS

AMWL

ASND

ASPN

ATRC

AVXL

AYTU

BIIB

BROS

BXMT

CAMT

CGNX

CHEF

CNCK

CNDT

COOP

CRBG

CRSR

CRWS

CSCO

CTRE

CWST

DENN

EPRT

EQIX

FCPT

FSLY

GAIN

GILT

GLPG

GNRC

GOLD

GROW

HCSG

HOOD

HUBS

IREN

KRNT

MKSI

MLYS

MMLP

NMTC

OPRT

OTLY

PAYC

PEGA

PLMR

PODC

PXLW

PYPD

QDEL

QMCO

QTWO

Earnings Scheduled For February 12, 2025

Biogen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) will release its fourth-quarter financial results, before the opening bell, <a href="https://www.benzinga.com/quote/biib/earnings">on Wednesday, Feb. 12, 2025.</a>
Analysts expect the Cambridge, Massachusetts-based company to report quarterly earnings at $3.36 per share, up from $2.95 per share in the year-ago period. Biogen projects quarterly revenue of $2.42 billion, compared to $2.39 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Sage Therapeutics recently announced that its Board of Directors initiated a process to explore strategic alternatives and rejected the unsolicited, nonbinding proposal it received from Biogen for $7.22 per share.
Biogen shares fell 2.2% to close at $139.39 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/BIIB/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Citigroup analyst Geoff Meacham maintained a Neutral rating and cut the price target from $190 to $160 on Jan. 28, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Wells Fargo analyst Mohit Bansal maintained an Equal-Weight rating and slashed the price target from $190 to $165 on Jan. 10, 2025. This analyst has an accuracy rate of 73%.</li>
<li>BMO Capital analyst Evan Seigerman downgraded the stock from Outperform to Market Perform and cut the price target from $230 to $164 on Dec. 20, 2024. This analyst has an accuracy rate of 62%.</li>
<li>Needham analyst Ami Fadia downgraded the stock from Buy to Hold with a price target of $270 on Nov. 18, 2024. This analyst has an accuracy rate of 67%.</li>
<li>Oppenheimer analyst Jay Olson maintained an Outperform rating and cut the price target from $270 to $255 on Oct. 31, 2024. This analyst has an accuracy rate of 63%.</li>
</ul>
Considering buying BIIB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="572" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12032109/image-98-1024x572.png" alt="" class="wp-image-778054" style="width:505px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12032109/image-98-1024x572.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12032109/image-98-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12032109/image-98-768x429.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12032109/image-98.png 1113w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43623929/wall-streets-most-accurate-analysts-spotlight-on-3-utilities-stocks-delivering-high-dividend-yields-6">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Utilities Stocks Delivering High-Dividend Yields</a></li>
</ul>

Biogen Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

California-based EV startup Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) on Tuesday released a series of teaser images, accompanied by the message &#8220;a mirage takes shape Feb 19.&#8221;
What Happened: The teaser images feature tire marks on the sand and also an image of the underside of a vehicle. One of the pictures shows sand dunes as seen through the R1T&#8217;s gear tunnel.
&#8220;Let the countdown begin!,&#8221; Rivian said in a post reply on X. 
The cryptic images shared on email, as well as social media platform X, have customers guessing.
While some are predicting a sand color exterior, others expect an imminent launch of the R2T, a pickup truck variant of the company&#8217;s upcoming R2 vehicle. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">R2T?
&mdash; Ethan (@EZebroni) <a href="https://twitter.com/EZebroni/status/1889386475634008486?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Yet another expects a launch for R1X, a rumored rugged variant of the company&#8217;s R1 vehicles.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">R1X! The ruggedized version of the R1T. Longer suspension travel, reinforced bumpers and undercarriage. Built in winch. Quad motor with new types of lockers to mimic mechanical lockers.
&mdash; adjust.clinic (@LloydChiro) <a href="https://twitter.com/LloydChiro/status/1889385119276052533?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Popular tech YouTuber Marques Brownlee joined the guessing game and responded to the images with a short, &#8220;R2D2?&#8221; It is unclear what Brownlee intended with the response. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">R2D2?
&mdash; Marques Brownlee (@MKBHD) <a href="https://twitter.com/MKBHD/status/1889392266445467755?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Rivian currently has only two vehicle models for individual customers- the R1T truck and the R1S SUV, both priced over $70,000 in the U.S. 
However, the company is looking to <a href="https://www.benzinga.com/25/01/43214741/rivian-ceo-warns-legacy-automakers-against-underinvesting-in-evs-in-light-of-policy-shift-big-miscalculation-for-long-term">expand its total addressable market</a> with the R2 SUV expected to be priced around $45,000, in the same price range as Tesla&#8217;s best-selling Model Y SUV. R2 is expected to enter production in early 2026.
The company is also planning to start deliveries of its&nbsp;<a href="https://www.benzinga.com/news/24/03/37552684/rivian-almost-catches-up-to-teslas-ev-lineup-with-new-r2-r3-but-theres-no-cybertruck-fighter-yet" target="_blank" rel="noreferrer noopener">R3 crossover after the R2.</a>&nbsp;The crossover is expected to be priced lower than the R2 SUV but it is unclear whether the R3&#8217;s price will undercut the Tesla Model 3 or remain within the same range. The company unveiled the R3X, a performance variant of the R3, last year when it unveiled the R2 SUV. 
Rivian is slated to report its fourth-quarter results on Feb. 20 at 2 pm PT.
For the full year 2024, Rivian&nbsp;<a href="https://www.benzinga.com/tech/25/01/42807694/rivian-reports-2nd-highest-quarterly-ev-deliveries-as-2024-wraps-up" target="_blank" rel="noreferrer noopener">delivered 51,579 EVs</a>, within its guidance of 50,500 to 52,000 deliveries.
In the three months through the end of December, the company delivered 14,183 vehicles, its second-highest quarterly delivery numbers since it started deliveries in 2021. &nbsp;
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/02/43647669/tesla-releases-supervised-full-self-driving-in-mexico-says-hola-to-local-drivers">Tesla Releases Supervised Full Self-Driving In Mexico, Says &#8216;Hola&#8217; To Local Drivers</a></li>
</ul>
Image Courtesy of Rivian Automotive

RIVN

MKBHD Joins Guessing Game After Rivian Teases 'Mirage' Event For Feb. 19: What's Going On?

Mowi (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MHGVY#OTC">MHGVY</a>) reported quarterly earnings of $0.33 per share. This is a 17.86 percent increase over earnings of $0.28 per share from the same period last year. The company reported $1.60 billion in sales this quarter. This is a 4.30 percent increase over sales of $1.53 billion the same period last year.

MHGVY

Mowi Q4 EPS Adj. $0.33 Up From $0.28 YoY, Sales $1.60B Up From $1.53B YoY

Sysmex (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSMXY#OTC">SSMXY</a>) reported quarterly earnings of $0.09 per share. This is a 33.08 percent decrease over earnings of $0.13 per share from the same period last year. The company reported $816.73 million in sales this quarter. This is a 6.00 percent increase over sales of $770.50 million the same period last year.

SSMXY

Sysmex Q3 EPS $0.09 Down From $0.13 YoY, Sales $816.73M Up From $770.50M YoY

Allianz Chief Economic Advisor Mohamed El-Erian warned that while President Donald Trump&#8216;s evolving tariff strategy may deliver immediate gains, it risks longer-term economic damage through stagflation and eroded U.S. global influence.
What Happened: El-Erian explained on X that the Trump administration&#8217;s tariff strategy follows a three-pronged approach, as highlighted in a Bloomberg Opinion <a href="https://www.bloomberg.com/opinion/articles/2025-02-11/trump-s-early-tariff-wins-mask-future-risks">piece</a> Tuesday: broad duties for revenue and trade balance, targeted protection for industries like steel and aluminum, and strategic tariff threats for political leverage.
&#8220;America&#8217;s many structural advantages and its bigger and cyclically stronger economy give it the upper hand in most negotiations,&#8221; El-Erian wrote, citing recent success in trade disputes with Colombia. However, he cautioned that &#8220;uncertainty is a feature rather than a bug&#8221; in the current approach.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Posted earlier today: Some thoughts on the evolution of US tariff policy:<a href="https://t.co/pQ3wJWLaBU">https://t.co/pQ3wJWLaBU</a><a href="https://twitter.com/opinion?ref_src=twsrc%5Etfw">@opinion</a> <a href="https://twitter.com/hashtag/markets?src=hash&amp;ref_src=twsrc%5Etfw">#markets</a> <a href="https://twitter.com/hashtag/trade?src=hash&amp;ref_src=twsrc%5Etfw">#trade</a> <a href="https://twitter.com/hashtag/tariffs?src=hash&amp;ref_src=twsrc%5Etfw">#tariffs</a> <a href="https://twitter.com/hashtag/economy?src=hash&amp;ref_src=twsrc%5Etfw">#economy</a> <a href="https://t.co/Ovnr5WVSYD">pic.twitter.com/Ovnr5WVSYD</a>
&mdash; Mohamed A. El-Erian (@elerianm) <a href="https://twitter.com/elerianm/status/1889340333189746843?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The warning comes as Trump pledged to <a href="https://in.benzinga.com/markets/equities/25/02/43613133/trumps-25-tarrifs-a-self-inflicted-wound-says-economist-amid-warnings-of-fewer-american-jobs-peter-schiff-says-youll-pay-more-for-cars-and-homes">impose 25% tariffs</a> on metal imports without exemptions, sending U.S. steel stocks like Cleveland-Cliffs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) and Nucor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) soaring on Monday.
See Also: <a href="https://www.benzinga.com/markets/equities/25/02/43646506/dan-ives-says-palantir-could-be-next-oracle-or-salesforce-as-ai-boom-drives-massive-software-spending-highlights-8-10x-multiplier-effect">Dan Ives Says Palantir Could Be Next Oracle Or Salesforce As AI Boom Drives Massive Software Spending, Highlights 8-10x Multiplier Effect</a>
Why It Matters: Former Treasury Secretary Larry Summers echoed these concerns, <a href="https://in.benzinga.com/markets/equities/25/02/43613133/trumps-25-tarrifs-a-self-inflicted-wound-says-economist-amid-warnings-of-fewer-american-jobs-peter-schiff-says-youll-pay-more-for-cars-and-homes">stating on social media </a>that the proposed tariffs would lead to &#8220;fewer American jobs, more American inflation, and probably a bigger trade deficit.&#8221;
El-Erian highlighted particular risks for low-income consumers and companies still recovering from post-pandemic inflation. He argued that frequent use of tariffs could make America &#8220;a less reliable partner,&#8221; potentially reducing bilateral trade interactions.
&#8220;Trade is an intrinsically cooperative game,&#8221; El-Erian noted. &#8220;Playing it uncooperatively can benefit the more powerful party in the short term&#8230; But the longer that international trade is played as an uncooperative game, the bigger the welfare losses to everyone participating, including the U.S.&#8221;
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43646173/bitcoin-ethereum-dogecoin-dip-even-as-fed-chair-powell-says-no-to-cbdcs-analyst-says-btc-under-consolidation-but-next-big-move-could-be-likely">Bitcoin, Ethereum, Dogecoin Dip Even As Fed Chair Powell Says No To CBDC: Analyst Says BTC Under Consolidation But &#8216;Next Big Move&#8217; Likely</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Mohamed El-Erian Says Trump's 'Uncooperative' Tariff Play Can Benefit America, But Could Lead To 'Welfare Losses' In Long-Term

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) researcher Troy Teslike expects the company&#8217;s EV deliveries in the first quarter to fall below 400,000 units. The EV giant&#8217;s quarterly deliveries have not fallen below 400,000 since the third quarter of 2022. 
What Happened: As per Teslike, who tracks Tesla delivery and production numbers, vehicle deliveries may be negatively impacted by limitations in ramping the production of the refreshed Model Y vehicle, poor brand sentiment, and the seasonal nature of vehicle demand. 
However, vehicle deliveries in the quarter could also be positively impacted by the launch of the new Model Y, the researcher noted.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Hi everyone. I expect Tesla deliveries this quarter to be below 400,000 units. There are four negative and one positive factor affecting deliveries: <a href="https://t.co/JU72e9NBy0">https://t.co/JU72e9NBy0</a> • Negative: Model Y Juniper production limitations • Negative: Seasonality • Negative: Demand pulled…
&mdash; Troy Teslike (@TroyTeslike) <a href="https://twitter.com/TroyTeslike/status/1889349816880165271?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
For the full year 2025, Teslike expects deliveries to be <a href="https://www.benzinga.com/25/01/43375903/tesla-researcher-estimates-drop-in-ev-deliveries-for-2025-despite-promise-of-new-models">below the numbers reported in 2024</a>. Tesla reported global&nbsp;<a href="https://www.benzinga.com/trading-ideas/movers/25/01/42766117/tesla-stock-tumbles-on-q4-deliveries-whats-going-on" target="_blank" rel="noreferrer noopener">deliveries of 1.79 million</a>&nbsp;vehicles in 2024, down from full-year deliveries of 1.81 million in 2023, marking the first decline in over a decade.
Tesla CEO Elon Musk said in October that he expects a 20-30% increase in deliveries in 2025. However, the CEO didn&#8217;t reiterate the target during the company&#8217;s fourth-quarter earnings in January. Instead, Tesla only said that it expects the vehicle business to &#8220;return to growth&#8221; in 2025. 
&#8220;I interpret this to mean Tesla's target is 1,790,000 units. This looks difficult to me. My estimate is lower,&#8221; Teslike said on Tuesday. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Elon previously mentioned 20-30% growth, but since he didn't repeat this in the last earnings call, it's no longer considered a target. Instead, Tesla said this: Tesla: &quot;We expect the vehicle business to return to growth in 2025&quot; Source (page 12): <a href="https://t.co/jWK71ucc02">https://t.co/jWK71ucc02</a> With…
&mdash; Troy Teslike (@TroyTeslike) <a href="https://twitter.com/TroyTeslike/status/1889351313273614643?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Tesla launched the refreshed version of Model Y, its best-selling vehicle, in January. 
The company commenced production of the refreshed vehicle less than two weeks ago across its four vehicle factories around the world in Califonia, Texas, Shanghai, and Berlin. Deliveries of the vehicle are slated to start in March.
Musk&nbsp;said during the company's earnings call last month that the company will&nbsp;<a href="https://www.benzinga.com/25/01/43328898/elon-musk-warns-teslas-new-model-y-will-result-in-several-weeks-of-lost-production-for-ev-giant-in-q1" target="_blank" rel="noreferrer noopener">lose production in the days of retooling&nbsp;</a>factories to prepare for production of the refreshed vehicle. The CEO also warned that margins will be impacted due to idle capacity and other ramp-related costs. However, these challenges will be overcome once production is ramped, he said.
Tesla last reported quarterly deliveries below 400,000 units <a href="https://www.benzinga.com/general/education/24/10/41166723/how-many-evs-has-tesla-delivered-produced-each-quarter-a-look-at-the-results-since-2019">in the third quarter of 2022</a>. The company delivered just 365,923 vehicles in that quarter. 
In the last quarter of 2024, Tesla reported 495,570 deliveries after resorting to offers and discounts across geographies. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43614443/tesla-starts-production-at-shanghai-megafactory-in-less-than-9-months-of-beginning-construction">Tesla Starts Production At Shanghai Megafactory Less Than 9 Months After Beginning Construction</a></li>
</ul>
Image via Shutterstock

TSLA

Tesla Q1 Deliveries Could Drop Below 400,000 As Brand Sentiment Takes A Hit, Says Researcher

2025 outlook: underlying operating margin of around 4%; mid- to high-single-digit underlying EPS growth; free cash flow of at least €2.2 billion; and gross capital expenditures of around €2.7 billion

Guidance

ADRNY

Koninklijke Ahold Delhaize Forecasts 2025 Outlook: ~4% Operating Margin, Mid- To High-Single-Digit EPS Growth, €2.2B+ Free Cash Flow, And €2.7B in Capital Expenditures

Koninklijke Ahold Delhaiz (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADRNY#OTC">ADRNY</a>) reported quarterly earnings of $0.74 per share. This is a 6.33 percent decrease over earnings of $0.79 per share from the same period last year. The company reported $24.84 billion in sales this quarter. This is a 0.24 percent increase over sales of $24.78 billion the same period last year.

Koninklijke Ahold Delhaiz Q4 Adj. EPS $0.74 Down From $0.79 YoY, Sales $24.84B Up From $24.78B YoY

With U.S. stock futures trading slightly lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) to report quarterly earnings at 93 cents per share on revenue of $97.19 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. CVS Health shares gained 1.3% to close at $55.00 on Tuesday.</li>
<li>Pitney Bowes Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBI#NYSE">PBI</a>) reported better-than-expected earnings for its fourth quarter and named Bob Gold as its new CFO. The company also said it sees FY2025 adjusted earnings of $1.10 to $1.30 per share on sales of $1.950 billion to $2.000 billion. Pitney Bowes shares jumped 9.8% to $9.60 in the after-hours trading session.</li>
<li>Analysts are expecting The Kraft Heinz Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>) to post quarterly earnings at 78 cents per share on revenue of $6.66 billion. The company will release earnings before the markets open. Kraft Heinz shares gained 0.2% to $29.65 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Zillow Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/Z#NASDAQ">Z</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZG#NASDAQ">ZG</a>) reported worse-than-expected earnings for its fourth quarter and issued weak revenue guidance for the first quarter. The company said it sees first-quarter sales of $575.000 million to $590.000 million versus market estimates of $600.20 million. Zillow shares dipped 6.3% to $80.90 in the after-hours trading session.</li>
<li>Analysts expect Cisco Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) to post quarterly earnings at 91 cents per share on revenue of $13.87 billion after the closing bell. Cisco shares gained 0.1% to $62.49 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43623929/wall-streets-most-accurate-analysts-spotlight-on-3-utilities-stocks-delivering-high-dividend-yields-6">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Utilities Stocks Delivering High-Dividend Yields</a></li>
</ul>

CVS Health, Kraft Heinz And 3 Stocks To Watch Heading Into Wednesday

Shopify Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) announced that it has captured 12% of the U.S. e-commerce market share, expanding from its origins as a platform for small businesses.
What Happened: During its <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43636620/shopifys-revenue-growth-outpaces-estimates-but-paypal-related-margin-impact-raises-questions-analyst">fourth quarter of 2024 earnings call</a>, the e-commerce giant revealed this milestone alongside a strategic push into enterprise-level commerce. As of June 2022, Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) dominated the U.S. e-commerce market with a 37.8% share, according <a href="https://www.statista.com/statistics/274255/market-share-of-the-leading-retailers-in-us-e-commerce/">to</a> Statista.
The company&#8217;s enterprise momentum has accelerated notably, with major brands including Reebok, Champion, Warner Music Group, and David&#8217;s Bridal joining the platform in the fourth quarter. Shopify President Harley Finkelstein highlighted a dramatic shift in enterprise interest, noting that &#8220;pretty much every retailer and every major brand on the planet is now looking to Shopify,&#8221; a marked change from just 12 months ago.
See Also: <a href="https://www.benzinga.com/markets/equities/25/02/43647866/robinhood-director-baiju-bhatt-sells-5-million-in-options-ahead-of-q4-earnings">Robinhood Director Baiju Bhatt Sells $5 Million In Options Ahead Of Q4 Earnings</a>
Why It Matters: A key competitive advantage has emerged in Shopify&#8217;s implementation speed, with the platform capable of launching major brands in three months compared to the traditional 12-18-month timeline. This efficiency is complemented by a significant cost advantage, with Ernst &amp; Young reporting that Shopify&#8217;s architecture enables a 22% lower cost of ownership for enterprise retailers.
The company has strengthened its enterprise position through strategic partnerships with major system integrators including WPP, EY, IBM, and Oracle, who are building dedicated Shopify implementation practices. 
Shopify has a <a href="https://www.benzinga.com/quote/SHOP/analyst-ratings">consensus price target</a> of $100.69 from 35 analysts, with a high of $175 and a low of $65. Recent ratings from Citigroup, RBC Capital, and Wedbush average $143.33, implying a 16.11% upside.
<figure class="wp-block-image aligncenter size-large is-resized"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12012129/Screenshot-2025-02-12-at-11.50.48%E2%80%AFAM-1024x385.png" alt="" class="wp-image-777834" style="width:785px;height:auto" /></figure>
Price Action: Shopify stock closed at $123.59 on Tuesday, up 3.08%. After-hours, it dipped 0.11% to $123.45. Year to date, shares have gained 14.94%, rising 38.68% over the past year, according to <a href="https://www.benzinga.com/pro/" target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/02/43646506/dan-ives-says-palantir-could-be-next-oracle-or-salesforce-as-ai-boom-drives-massive-software-spending-highlights-8-10x-multiplier-effect">Dan Ives Says Palantir Could Be Next Oracle Or Salesforce As AI Boom Drives Massive Software Spending, Highlights 8-10x Multiplier Effect</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

AMZN

Shopify Secures 12% Of US E-Commerce Pie As Reebok, Champion, And Warner Music Join Platform

SoftBank Group (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBY#OTC">SFTBY</a>) reported quarterly losses of $(0.83) per share. This is a 138.07 percent decrease over earnings of $2.18 per share from the same period last year. The company reported $12.03 billion in sales this quarter. This is a 0.16 percent increase over sales of $12.01 billion the same period last year.

SFTBF

SFTBY

SoftBank Group Q3 EPS $(0.83) Down From $2.18 YoY, Sales $12.03B Up From $12.01B YoY

Press Releases

Actuate Therapeutics Obtains Complete Responses and Provides Update on Clinical Trial of Elraglusib for the Treatment of Relapsed/Refractory Ewing Sarcoma

Health Care

Actuate Receives FDA Orphan Drug Designation for Elraglusib for Treatment of Soft Tissue Sarcomas

Actuate Announces Upcoming Presentation on Initial Data on Elraglusib in Combination with FOLFIRINOX at the AACR Special Conference on Advances in Pancreatic Cancer Research

Actuate Announces Scientific Reports Publication on Elraglusib's Novel Immunomodulatory Mechanism of Action as a GSK-3β Inhibitor

Actuate to Participate in Lantern's Pharma Webinar on AI-Driven Drug Development

Actuate Announces FDA Rare Pediatric Disease Designation Granted to Elraglusib for Treatment of Ewing Sarcoma

Actuate Therapeutics to be Added to Russell 2000® Index

Actuate Therapeutics Announces Positive Interim Phase 2 Data of Elraglusib in First Line Treatment of Metastatic Pancreatic Cancer

Actuate Therapeutics Receives EMA Orphan Medicinal Product Designation for Elraglusib for the Treatment of Pancreatic Cancer

Actuate Therapeutics to Participate in Upcoming Investor Conferences in February

Comments

Actuate Therapeutics

Actuate Therapeutics (ACTU) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga